Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Clinical trial NCT02964078 · COMPLETED
Trial details
- NCT number
- NCT02964078
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2019-03-26
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.